A Procurement Manager's Checklist for Evaluating NuVasive After the Globus Medical Merger

Who This Checklist is For (and When to Use It)

This is for procurement managers, supply chain directors, and surgery center administrators. Specifically, for anyone who is now reviewing their spinal implant vendor contracts in light of the NuVasive/Globus Medical merger.

If your hospital is currently using NuVasive products (or considering a switch), and you're being approached by sales reps with new bundled pricing or warranties, you need this. The market shifted in 2024. What worked last year might not be the best deal today.

This checklist covers 5 steps. It's not theoretical. I've been tracking our spinal implant spend for six years, and the merger triggered a complete re-evaluation of our agreements. Here's what I do step-by-step.

Step 1: Audit Your Current Contract for the 'NuVasive Legacy' Terms

Before looking at any new proposals, pull your existing NuVasive contract. Look specifically at the fine print for clauses tied to their pre-merger structure. I found a few surprises.

Things to check:

• Clinical support fees: Were surgical technique support (like access to their clinical education team or PDFs of surgical techniques) priced separately, or bundled? Post-merger, some of these services might be reclassified or offered under a Globus Medical umbrella. (I found a line item for 'Advanced Surgical Technique PDF access'—which was suddenly moved to a premium tier.)
• Minimum order commitments: Check for any MOQs that might now apply to a combined product catalog. Just because you bought only NuVasive implants before doesn't mean a combined minimum isn't now being proposed.
• Warranty and instrument loaner terms: NuVasive's Reline surgical system had specific loaner instrument terms. Globus may have different policies. Get this in writing.

Step 2: Map Your 'Total Cost of Ownership' (TCO) for a Single Procedure

This is where most people get tripped up. They look at the implant list price and forget the rest. I built a simple TCO spreadsheet after getting burned on hidden fees twice.

For a standard ALIF or TLIF procedure, break down:

• Implant cost: The base price for the cage, screws, rods.
• Instrumentation & loaner fees: Does the contract cover the cost of loaner instrument trays? One vendor we evaluated charged a per-day fee that added $1,200 to a two-day case (ugh).
• Clinical support & training: Will a NuVasive rep be on-site for the first five cases? Is that included? For longer cases or complex anatomies, having a rep who knows the system is critical. The value of guaranteed turnaround for that support (think: the certainty of having an expert available) often outweighs the cost.
• Revision & return costs: What happens if a screw is the wrong size? Some vendors charge a restocking fee. Others require you to buy a whole new kit. This is a huge hidden cost.

For example: In Q3 2024, I compared costs for a 20-procedure run using four vendors. Vendor A quoted $45,000 for implants. Vendor B quoted $41,000. I almost went with B until I calculated TCO: B charged $2,500 for instrument loaners, $1,800 for rep on-site support, and $900 in restocking fees. Total: $46,200. Vendor A's $45,000 included everything. That's a 3% difference hidden in fine print.

Step 3: Evaluate the 'Globus Medical' Portfolio Synergy (Don't Just Assume It's Better)

The conventional wisdom is that the merger means a single, cheaper, combined catalog. In practice, I found it's not that simple. The combined portfolio has strengths, but you have to check for gaps.

Specifically, look at the surgical technique guidelines. The 'NuVasive Reline surgical technique PDF' is a great example of a well-documented procedure. But does the new combined sales team still support it with the same priority? Or are they now pushing a Globus product that's a 'similar' but not identical approach? (To be fair, Globus has excellent products, but switching technique mid-stream without retraining your surgeons is risky.)

My advice: Ask your NuVasive rep for the 2025 combined portfolio document. If they cannot produce a clear, line-item comparison of which legacy NuVasive products are 'primary' vs. 'secondary' in the new portfolio, that's a red flag.

Step 4: Build a 'Risk-Adjusted' Price for Time-Critical Cases

This is the step most procurement teams skip. We think in terms of unit price. But for spinal surgery, delivery certainty is a premium feature.

For a scheduled elective case, the cheapest implant wins. For a trauma or revision case that needs to happen within 48 hours, you cannot afford a vendor that says 'probably can ship by Friday' (ugh, again). That 'probably' could mean a cancelled case, a delayed discharge, and a lot of unhappy surgeons.

So, in your vendor evaluation, explicitly add a line item for 'Rush Delivery & Emergency Availability'. Ask each vendor:

• What is your guaranteed turnaround for a custom kit for a complex TLIF? (e.g., 'We guarantee shipment within 24 hours of the order, or we credit you 10% of the kit price.')
• Can you provide a single point of contact for emergency cases on weekends?

In March 2024, we paid $2,000 extra on a single order for guaranteed weekend delivery. The alternative was missing a $45,000 surgery that was already scheduled. That 'cheap' option with the uncertain timeline was actually the more expensive risk.

This is where the NuVasive/Globus combined supply chain might offer an edge—they have multiple distribution hubs. But get the guarantee in writing.

Step 5: Negotiate on the 'Value-Add' Services (Not Just the Implant Price)

This is where you have leverage. After the merger, both the NuVasive and Globus sales teams are trying to retain and grow their customer base. They know contracts are up for review.

Instead of asking for a 10% discount on the implant price (which they likely cannot give without destroying value), push for:

• Free surgical technique training: Ask for 2-3 on-site training sessions per year for your surgical team. This saves you $4,000-8,000 annually on external courses.
• Revised restocking terms: Ask for a zero-restocking-fee policy for the first year. If they say no, ask for a maximum of 5%.
• Access to the full PDF library: Demand continued access to the full NuVasive Reline surgical technique PDF library and any Globus equivalents. This is a crucial clinical resource for training new residents and PAs.
• Data & analytics: Ask for quarterly reports on your implant usage, case costs, and inventory. A good vendor will provide this to help you optimize your ordering.

Important: Watch Out For These Common Mistakes

After running through this checklist with 3 different vendor evaluations this year, here are the top 2 traps:

1. The 'Bundled Only' Trap: Some vendors will try to bundle all NuVasive and Globus products into a single contract with a 'volume discount.' This sounds great, but it locks you into buying everything from one source. If you need a specialized Globus product that your NuVasive-preferred surgeons don't like, you lose flexibility. I watched a hospital group get burned by this—they saved 5% on a bundle but then couldn't use a critical NuVasive-only instrument for a specific procedure.
2. The 'Forgetting SpO2 & OR Table Compatibility': This seems obvious, but in the rush to negotiate implants, people forget that spinal surgery equipment (like the operating table) and patient monitoring (like portable oxygen concentrators and SpO2 monitors for post-op recovery) might need to be compatible with the new implant systems. Ask the vendor: 'Does your new instrumentation work with a standard Jackson table? Or do we need to buy an additional table?' This is a $15,000+ question.

Prices and terms as of January 2025; verify current offerings with your NuVasive/Globus Medical rep. The market is still settling post-merger, so there's leverage to be found—but you have to look carefully.